Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Harvard Bioscience spin-off is stepping up its production of synthetic tracheas to supply clinical trials.
By delivering gene therapies to patients before they go blind, doctors may be able to prevent the loss of many important light-detecting cells.
Illumina announces a new high-end sequencer made for “factory-scale” sequencing of human genomes.
A paralyzed man will receive experimental surgery connecting a brain chip to systems that activate muscles in his arm.
A former hockey player founded a company to give athletes and families a better way to identify brain injuries.
The ability to print retinal cells could lead to new therapies for retinal disorders such as macular degeneration.